Massachusetts General Hospital Reproductive Endocrinology and Infertility

Topics

• Ovarian function and disorders 266
• Effects and risks of endocrine disrupting chemicals 230
• Menopause: Health Impacts and Treatments 172
• Reproductive Biology and Fertility 112
• Endometriosis Research and Treatment 64
• Sperm and Testicular Function 63
• Reproductive Health and Technologies 61
• Uterine Myomas and Treatments 50
• Assisted Reproductive Technology and Twin Pregnancy 42
• Toxic Organic Pollutants Impact 41
• Congenital Diaphragmatic Hernia Studies 36
• Air Quality and Health Impacts 34

Most cited

1. The Menopause Transition: Signs, Symptoms, and Management Options.

   The Journal of clinical endocrinology and metabolism · 2021 · 411 citations · Nanette Santoro

2. ASRM müllerian anomalies classification 2021.

   Fertility and sterility · 2021 · 258 citations · John Petrozza

3. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.

   Lancet (London, England) · 2023 · 196 citations · Nanette Santoro

4. Menopause-Biology, consequences, supportive care, and therapeutic options.

   Cell · 2023 · 159 citations · Nanette Santoro

5. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT.

   The Journal of clinical endocrinology and metabolism · 2023 · 148 citations · Nanette Santoro

6. Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

   Circulation · 2023 · 144 citations · Jan Shifren

7. Menarche and Time to Cycle Regularity Among Individuals Born Between 1950 and 2005 in the US.